
Madrigal Pharmaceuticals, Inc.
USD527.28
+14.63 (+2.85%)
CEO
William J. Sibold
IPO Date
2007-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$517.99
Prev. Close
$512.65
Day Low
$506.00
Day High
$531.04
52W Low
$284.02
52W High
$615.00
Market Cap
$12.16B
Volume
0.45M
Madrigal Pharmaceuticals Completes Enrollment of the 52 Week Liver Biopsy Patient Population in the Phase 3 MAESTRO-NASH Study of Resmetirom